Xyzal and Vancomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xyzal (levocetirizine dihydrochloride) and Vancomycin (vancomycin). Common drug interactions include drug hypersensitivity among females and haemoptysis among males.

The phase IV clinical study analyzes what interactions people have when they take Xyzal and Vancomycin. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Xyzal?

Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.



On May, 07, 2026

15 people who take Xyzal and Vancomycin together, and have interactions are studied.

Xyzal and Vancomycin drug interactions.

What are the common drug interactions of Xyzal and Vancomycin, by gender? *:

female:

  1. Drug hypersensitivity
  2. Nausea (feeling of having an urge to vomit)
  3. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  4. Pyrexia (fever)
  5. Blood creatine phosphokinase increased
  6. Drug ineffective
  7. Erythema (redness of the skin)
  8. Pain of skin
  9. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  10. Skin lesion

male:

  1. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  2. Abdominal distension
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Genital abscess (build up of pus in genital)
  5. Headache (pain in head)
  6. Influenza
  7. Insomnia (sleeplessness)
  8. Intestinal obstruction
  9. Joint swelling
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Xyzal and Vancomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood creatine phosphokinase increased
  2. Drug hypersensitivity
  3. Drug ineffective
  4. Erythema (redness of the skin)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain of skin
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Pyrexia (fever)
  9. Skin lesion

30-39:

  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)
  3. Pyrexia (fever)
  4. Abdominal distension
  5. Acne (skin problems that cause pimples)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Arthralgia (joint pain)
  8. Back pain
  9. Blood glucose increased
  10. C-reactive protein increased

40-49:

  1. Chronic kidney disease
  2. Drug hypersensitivity
  3. Gastritis (inflammation of stomach)
  4. Obesity (having too much body fat)
  5. Pain
  6. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  7. Renal failure (kidney dysfunction)
  8. Surgery
  9. Temperature intolerance (inability to go in temperature)

50-59:

  1. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)

60+:

  1. Aspartate aminotransferase increased
  2. Anal abscess
  3. Scrotal gangrene (death of scrotum cells)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Septic shock (shock due to blood infection)
  6. Urinary tract infection
  7. Genital abscess (build up of pus in genital)
  8. Haemoglobin decreased
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

  1. Colorectal Cancer Stage Iv (cancer of colon and rectal spreads to liver or lung): 2 people, 13.33%
  2. Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 13.33%
  3. Indigestion: 2 people, 13.33%
  4. Cystic Fibrosis (disease of the secretary glands): 2 people, 13.33%
  5. K-Ras Gene Mutation: 2 people, 13.33%
  6. Constipation: 1 person, 6.67%
  7. Gastric Ulcer (stomach ulcer): 1 person, 6.67%
  8. Endometrial Cancer: 1 person, 6.67%
  9. Drowsiness: 1 person, 6.67%
  10. Diabetes: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Xyzal and Vancomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xyzal and Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xyzal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xyzal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levocetirizine dihydrochloride and vancomycin (the active ingredients of Xyzal and Vancomycin, respectively), and Xyzal and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: